Home / Recalls / Hospira Inc. / Z-1751-2013

Z-1751-2013 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA device recall Z-1751-2013 was initiated by Hospira Inc. on Jun 18, 2013 and is designated Class II. Reason for recall: Hospira has received reports of customers experiencing air-in-line alarms related to administration sets that have a drip chamber with a ball valve. Preliminary investigation findings found that there… The recall status is terminated (terminated Nov 7, 2016). Affected quantity: 14,400 units.

Recall Details

Product Type: Devices
Report Date: Jul 24, 2013
Initiation Date: Jun 18, 2013
Termination Date: Nov 7, 2016
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 14,400 units

Product Description

LifeShield; Sterile; Rx only; List No. 19666-28; SYMBIQ PUMP SET, CONVERTIBLE PIN, PIGGYBACK, 2 CLAVES PORTS AND OPTION LOK, NON-DEHP; NOMINAL LENGTH: 97 IN (249 CM); PRIMING VOLUME: 14 ML; For the administration of I.V. fluids; Made in Costa Rica; Hospira, Inc., Lake Forest, IL 60045 USA The Hospira Symbiq Infusion System is a general infusion system which provides IV infusion across the general spectrum of clinical care. The Symbiq pumps are standard sized pumps which are typically facility-based infusion pumps which may be used to deliver continuous and/or intermittent infusions to a variety of patient populations.

Reason for Recall

Hospira has received reports of customers experiencing air-in-line alarms related to administration sets that have a drip chamber with a ball valve. Preliminary investigation findings found that there is a potential for the ball valve to not seal the drip chamber as intended, leading to air in the line of the administration set.

Distribution Pattern

Worldwide Distribution - US (nationwide) including the states of IA, IL, MN, SD and WA., and Costa Rica.

Code Information

List Number: 19666-04-28; Lot Number: 87-188-5H

Source

Dataset: openFDA device recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for Z-1751-2013
openFDA file date: Oct 27, 2026
Loaded by RegDataLab: Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Hospira Inc.

D-0862-2017 Class I — Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use… (Apr 21, 2017)
D-0153-2017 Class II — Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL… (Nov 1, 2016)
D-1500-2016 Class II — DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be… (Aug 15, 2016)
D-0169-2017 Class III — 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5… (Jun 29, 2016)
D-1359-2016 Class II — Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake… (Jun 23, 2016)
D-1033-2016 Class II — Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only… (May 6, 2016)
Z-1833-2016 Class II — The Plum A+ is a dual-line volumetric infusion system designed to meet the… (Mar 25, 2016)
Z-1832-2016 Class II — The Plum 360 is a large volume infuser capable of delivering fluids for a… (Mar 25, 2016)
D-1137-2016 Class I — Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20… (Mar 23, 2016)
D-0854-2016 Class III — Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20… (Mar 23, 2016)